Hematology

Filter

Konstanze Döhner, President Elect, European Hematology Association (EHA); Department of Internal Medicine III, University Hospital of Ulm, Germany.

EHA Interview 2025: Konstanze Döhner

September 2025

EMJ spoke with Konstanze Döhner, President Elect of the European Hematology Association, about her priorities for the future of haematology, challenges in research and patient care, and the vision behind the EHA2025 theme “Borderless Hematology”.

AML Expert-Led Webinar: Exploring Maintenance Approaches in AML

Watch Part 2 of the Expert Webinar series on acute myeloid leukaemia (AML) maintenance therapy (catch up on Part 1 of the…

Highlights on Pierre Fabre EHA 2024 Symposium: Changing the face of EBV+ PTLD with allogeneic T-cell therapies

Watch here the key takeaways from this year’s European Hematology Association (EHA) symposium that focused on the Management…

The ITP Treatment Landscape

In this video, discover updates in the treatment of immune thrombocytopaenia, with a focus on patient perspectives and unmet clinical needs.

Bridging Generations in Immune Thrombocytopenia (ITP): Adult and Pediatric Perspectives

Watch the highlights and expert interviews from the Sobi symposium ‘Bridging Generations in ITP Care: Adult and Pediatric Perspectives’…

Impact of Normalisation of Haemostasis for People with Haemophilia A

Explore insights on the normalisation of haemostasis in people with Haemophilia A, featuring highlights from the Sobi symposium at EHA 2024

The latest issue of EMJ Hematology

Get the latest insights from the European Hematology Association Congress, featuring an infographic on platelet disorders and innovative…

Talk with the Experts: Clinical Case Studies and Treatment Decisions in Acute Myeloid Leukemia and Myelofibrosis

Catch up on this expert-led Satellite Symposium, titled ‘Talk with the Experts: Clinical Case Studies and Treatment Decisions in Acute…

Phase III IMROZ Study of Isa-VRd in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Watch Thierry Facon highlight the Phase III IMROZ study: a global, randomised, Phase III, open-label study evaluating the efficacy and…

Loading posts...

« Previous 1 2 3 4 … 10 Next »